Sentences with phrase «on pharmaceutical litigation»

Currently, Ms. Butler focuses on pharmaceutical litigation, as well as whistleblower / qui tam cases and Medicare fraud cases.

Not exact matches

Jazz said in a filing that it did so in response to the overall takeover environment for pharma companies and in light of a patent litigation settlement that allows Hikma Pharmaceuticals to sell a generic version of Xyrem with Jazz receiving royalty payments on those sales.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.

After focusing on pharmaceutical patent and trade - mark litigation for most of her career, Paula now advises on IP strategy in the biotech sector.

Harlan Prater's three decades of law practice have been devoted to all types of high - stakes civil trial work, with a focus on product liability and pharmaceutical and medical device litigation.

Harlan Prater has devoted his career to all types of high - stakes civil trial work, with a focus on product liability and pharmaceutical and medical device litigation.

John concentrates his practice on representing corporate clients in tort defense, products liability, mass torts, class actions, toxic torts, asbestos, litigation management, food liability, professional liability, pharmaceutical and medical device litigation, environmental litigation, intellectual property litigation, construction defect litigation, general liability, premises liability, and business and insurance disputes.

We regularly advise leading businesses on high - profile litigation, including class actions and mass tort claims arising from product defects across a wide range of sectors, from consumer electronics, automotive, medical devices and pharmaceuticals to industrial machinery, aerospace and chemicals.

Lorraine has provided consulting services on all phases of eDiscovery in litigation and investigations to public and private companies in various industries including energy and natural resources, financial services, telecommunications, healthcare, the pharmaceutical sector, and heavy manufacturing.

Mr. Buczko's practice focuses on patent litigation and he has represented clients in the biotechnology, pharmaceutical, chemical and electronics industries.

Andrew Kruppa chairs the Litigation Practice Group in Miami and focuses his practice on defending claims against manufacturers of pharmaceuticals and medical devices.

We offer full range of IP services for pharmaceutical clients, having multiple pharmaceutical lawyers on staff with years of experience in prosecution, opinion work, and litigation.

Represented multinational pharmaceutical company in product liability litigation in courts across the country and before the Judicial Panel on Multidistrict Llitigation in courts across the country and before the Judicial Panel on Multidistrict LitigationLitigation.

This blawg «reports on Hatch - Waxman litigation and other pharmaceutical patent cases, as well as regulatory and legislative developments.»

Fred Roth, an associate in Chicago, has experience working on litigation and regulatory compliance as it applies to medical devices and pharmaceuticals.

As one of the nation's leading lawyers in the emerging field of state unclaimed property laws, John devotes a substantial part of his practice to representing and advising a variety of manufacturers, retailers, distributors, financial institutions, pharmaceutical companies, telecommunications and transportation companies, utilities, service providers and other types of businesses on complex multi-state unclaimed property audits, litigation, voluntary disclosure agreements and transactional issues.

Served on one of 5 designated trial teams for a Fortune 10 company in nationwide pharmaceutical litigation.

Mr. Byrd's practice focuses on the areas of energy, securities, and pharmaceutical litigation.

Shrestha focuses his practice on all aspects of intellectual property law, including patent litigation, prosecution and opinion work in the chemical, pharmaceutical and electronic material arts.

Her practice focuses on biotechnology and pharmaceutical matters, including patents, licensing, and related litigation.

Tarifa Laddon concentrates her practice on a diverse range of complex business litigation matters, including pharmaceutical and medical device litigation, toxic tort, financial services litigation, unfair business practice claims, business torts and wage and hour and consumer class action defense.

His practice focuses largely on the litigation of complex disputes involving common law, statutory law, contract law, physician and hospital liability law, products liability law, commercial, corporate and business issues, catastrophic personal injury cases and class action / mass torts / pharmaceutical litigation.

Dr. Nemirow specializes in intellectual property law with an emphasis on patent prosecution and litigation, particularly in the chemical, pharmaceutical, and biotech fields.

Mr. Sistrunk's practice focuses largely on the litigation of complex disputes involving common law, statutory law, contract law, physician and hospital liability law, product liability law, commercial, corporate and business issues, catastrophic personal injury cases and class action / mass torts / pharmaceutical litigation.

Prior to joining Lewis Wagner, Meghan was an associate in the New York firm Traub Lieberman Straus & Shrewsberry's insurance coverage group, where she represented insurance company clients in insurance coverage litigation, and advised insurers on exposure and liability issues in wide array of tort and commercial contexts, including mass tort and class action litigation involving pharmaceuticals, chemical, transportation, news and entertainment, and oil and gas; environmental suits; FDA compliance claims; unfair competition and false advertising claims; intellectual property claims; construction defect; personal injury; product liability; and associated breach of contract claims.

On September 23, Canada's Competition Bureau («the Bureau») announced landmark guidelines regarding the consideration of pharmaceutical patent litigation settlements under Canada's competition law framework.

On the panel were some heavyweights: Jason Barnwell, an assistant general counsel of Microsoft, Teresa Britton, manager of records for Exelon Corporation, a large energy company, and Jack Thompson, manager of litigation support for Sanofi, a French pharmaceutical company.

Mr. Pletcher is an experienced trial lawyer with a focus on cases involving commercial business disputes, products liability, professional negligence, and employment, health care, pharmaceutical, medical device and biotech litigation and civil appeals.

As we reported, Canada implemented a single - track pharmaceutical patent litigation regime through amendments to the Patented Medicines (Notice of Compliance) Regulations (the Regulations) on September 21, 2017.

Jonathan's practice is focused on mass tort product liability litigation involving defective medical devices and pharmaceutical drugs.

Julie is committed to helping her clients fight back against big corporations and pharmaceutical companies, and focuses on medical malpractice, product liability and personal injury, though she also has experience with commercial litigation and class actions.

She focuses her practice on the representation of injured parties in professional negligence and personal injury litigation, pharmaceutical and medical device products liability litigation.

Before joining Arent Fox in 2004, Ricardo was a partner in a major law firm in the city of Caracas, Venezuela where he represented various pharmaceutical, food, and entertainment companies doing business in Venezuela and South America in areas including foreign investment requirements and compliance, regulatory compliance with focus on food and pharmaceuticals, and intellectual property — namely trademark protection and litigation, data access, and privacy and patent litigation (mostly design patent).

At Gacovino, Lake & Associates, P.C., we pride ourselves on our experience with personal injury and dangerous products litigation, including pharmaceutical drugs and medical devices, which require specialized knowledge and training in state and federal laws.

Daniel B. Carroll represents clients in a wide range of litigation with a primary focus on pharmaceutical products liability defense.

Mr. Girard currently serves on the leadership team in the Target and Sony data breach actions; serves as lead counsel in derivative litigation on behalf of Wal - Mart shareholders arising out of alleged bribery in Mexico, lead counsel for commodities investors in litigation arising out of the collapse of a commodities futures merchant, and lead counsel in a multi-district «pay for delay» antitrust proceeding against major pharmaceutical companies.

These same attorneys also have experience advising pharmaceutical companies on pre-regulatory approval activities, FDA regulations, and patent prosecution strategies which allow the companies to develop the strongest patent portfolio to assert during litigation.

Howard Nations has been at the forefront of civil and personal injury litigation for over 50 years and has built a national practice focused on mass tort pharmaceuticals, individual catastrophic injuries, and complex business litigation.

Chair of Houston Harbaugh's Intellectual Property Practice and Co-Chair of the Litigation Practice, Mr. Sneath is a trial attorney focusing on complex business litigation, intellectual property, patents, trademarks, trade secrets, DTSA, products and pharmaceutical liability, toxic torts, insurance coverage and bad faith, energy, catastrophic injury and tort litigatioLitigation Practice, Mr. Sneath is a trial attorney focusing on complex business litigation, intellectual property, patents, trademarks, trade secrets, DTSA, products and pharmaceutical liability, toxic torts, insurance coverage and bad faith, energy, catastrophic injury and tort litigatiolitigation, intellectual property, patents, trademarks, trade secrets, DTSA, products and pharmaceutical liability, toxic torts, insurance coverage and bad faith, energy, catastrophic injury and tort litigationlitigation matters.

Howard Nations has been at the forefront of civil and personal injury litigation for 50 years and has a national practice that focuses on mass tort pharmaceuticals and medical devices, individual catastrophic injuries, wrongful death, and complex business litigation.

The key patent cases that I have to address and consider currently in the chemical, pharmaceutical and biotechnological cases (however, it should be appreciated there are several more) are the recent Alice (patent subject matter eligibility), Shaw Industries Group, Inc. (accused infringers can use AIA review procedures without undermining their case in later litigation), Merck & Cie (PTAB AIA review decisions must be reviewed with deference on appeal) and In re Cuozzo Speed Technologies, LLC, (broadest reasonable interpretation for IPR versus ordinary meaning for litigation is appropriate) decisions as well as the USPTO's ever developing guidelines as to patent subject matter eligibility and obviousness determinations.

Sheryl Bjork concentrates her practice on the defense of complex mass tort product liability claims, representing some of the world's largest medical device and pharmaceutical manufacturers in individual, MDL, and class action litigation.

Her current practice focuses primarily on mass tort pharmaceutical and medical device litigation, hurricane - related takings and insurance denials, war veterans» claims under the Anti-Terrorism Act, and lawsuits related to the BP Oil Spill.

Kathleen's IP litigation practice focuses on patent, trademark, and copyright cases and disputes for clients ranging from major pharmaceutical companies to start - ups and senior executives.

Carol's practice focuses on patent filing and prosecution, patent - related legal advice and patent litigation across a broad range of industries, including chemistry, materials science, pharmaceutical, biotechnology, medical device, semiconductor and auto mechanics.

Sheryl has published numerous articles and CLE materials on current topics in medical device / pharmaceutical litigation, Minnesota product liability law, and settlement issues.

Riccardo Valle is a lawyer with our corporate team, focusing (in regards to transactional / litigation matters before Civil and Administrative Courts) in providing legal assistance to clients active in highly regulated markets, with specific focus on energy (including generation, infrastructures, incentives, PPA / EFET, and IPEX), environment (including waste, and EIA / IPPC), and pharmaceuticals (including AIFA regulations and wholesale distribution).

She has served as local counsel on more than 20 cases for a pharmaceutical company in MDL litigation in which she again deposed dozens of prescribing and treating physicians and their patients.

Representation of a global Fortune 50 pharmaceutical company as its primary e-discovery counsel; he counsels the company on litigation readiness, information management, data privacy and international discovery issues